Chronic Glucocorticoid-Rich Milieu and Liver Dysfunction
We investigated the impact of chronic hypercorticosteronemia (due to neonatal monosodium L-glutamate, MSG, and treatment) on liver oxidative stress (OS), inflammation, and carbohydrate/lipid metabolism in adult male rats. We evaluated the peripheral concentrations of several metabolic and OS markers...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2016/7838290 |
id |
doaj-ec9247c2618c451383164db374ae0eaf |
---|---|
record_format |
Article |
spelling |
doaj-ec9247c2618c451383164db374ae0eaf2020-11-24T23:10:05ZengHindawi LimitedInternational Journal of Endocrinology1687-83371687-83452016-01-01201610.1155/2016/78382907838290Chronic Glucocorticoid-Rich Milieu and Liver DysfunctionHernán Gonzalo Villagarcía0Vanesa Sabugo1María Cecilia Castro2Guillermo Schinella3Daniel Castrogiovanni4Eduardo Spinedi5María Laura Massa6Flavio Francini7Centro de Endocrinología Experimental y Aplicada (CENEXA), UNLP-CONICET-FCM, 1900 La Plata, ArgentinaCentro de Endocrinología Experimental y Aplicada (CENEXA), UNLP-CONICET-FCM, 1900 La Plata, ArgentinaCentro de Endocrinología Experimental y Aplicada (CENEXA), UNLP-CONICET-FCM, 1900 La Plata, ArgentinaCátedra de Farmacología Básica, Facultad de Ciencias Médicas, UNLP and CICPBA, 1900 La Plata, ArgentinaInstituto Multidisciplinario de Biología Celular (IMBICE), CONICET-CICPBA-UNLP, 1900 La Plata, ArgentinaCentro de Endocrinología Experimental y Aplicada (CENEXA), UNLP-CONICET-FCM, 1900 La Plata, ArgentinaCentro de Endocrinología Experimental y Aplicada (CENEXA), UNLP-CONICET-FCM, 1900 La Plata, ArgentinaCentro de Endocrinología Experimental y Aplicada (CENEXA), UNLP-CONICET-FCM, 1900 La Plata, ArgentinaWe investigated the impact of chronic hypercorticosteronemia (due to neonatal monosodium L-glutamate, MSG, and treatment) on liver oxidative stress (OS), inflammation, and carbohydrate/lipid metabolism in adult male rats. We evaluated the peripheral concentrations of several metabolic and OS markers and insulin resistance indexes. In liver we assessed (a) OS (GSH and protein carbonyl groups) and inflammatory (IL-1b, TNFa, and PAI-1) biomarkers and (b) carbohydrate and lipid metabolisms. MSG rats displayed degenerated optic nerves, hypophagia, low body and liver weights, and enlarged adipose tissue mass; higher peripheral levels of glucose, triglycerides, insulin, uric acid, leptin, corticosterone, transaminases and TBARS, and peripheral and liver insulin resistance; elevated liver OS, inflammation markers, and glucokinase (mRNA/activity) and fructokinase (mRNA). Additionally, MSG liver phosphofructokinase-2, glucose-6-phosphatase (mRNA and activity) and glucose-6-phosphate dehydrogenase, Chrebp, Srebp1c, fatty acid synthase, and glycerol-3-phosphate (mRNAs) were increased. In conclusion adult MSG rats developed an insulin-resistant state and increased OS and serious hepatic dysfunction characterized by inflammation and metabolic signs suggesting increased lipogenesis. These features, shared by both metabolic and Cushing’s syndrome human phenotypes, support that a chronic glucocorticoid-rich endogenous environment mainly impacts on hepatic glucose cycle, displacing local metabolism to lipogenesis. Whether correcting the glucocorticoid-rich environment ameliorates such dysfunctions requires further investigation.http://dx.doi.org/10.1155/2016/7838290 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Hernán Gonzalo Villagarcía Vanesa Sabugo María Cecilia Castro Guillermo Schinella Daniel Castrogiovanni Eduardo Spinedi María Laura Massa Flavio Francini |
spellingShingle |
Hernán Gonzalo Villagarcía Vanesa Sabugo María Cecilia Castro Guillermo Schinella Daniel Castrogiovanni Eduardo Spinedi María Laura Massa Flavio Francini Chronic Glucocorticoid-Rich Milieu and Liver Dysfunction International Journal of Endocrinology |
author_facet |
Hernán Gonzalo Villagarcía Vanesa Sabugo María Cecilia Castro Guillermo Schinella Daniel Castrogiovanni Eduardo Spinedi María Laura Massa Flavio Francini |
author_sort |
Hernán Gonzalo Villagarcía |
title |
Chronic Glucocorticoid-Rich Milieu and Liver Dysfunction |
title_short |
Chronic Glucocorticoid-Rich Milieu and Liver Dysfunction |
title_full |
Chronic Glucocorticoid-Rich Milieu and Liver Dysfunction |
title_fullStr |
Chronic Glucocorticoid-Rich Milieu and Liver Dysfunction |
title_full_unstemmed |
Chronic Glucocorticoid-Rich Milieu and Liver Dysfunction |
title_sort |
chronic glucocorticoid-rich milieu and liver dysfunction |
publisher |
Hindawi Limited |
series |
International Journal of Endocrinology |
issn |
1687-8337 1687-8345 |
publishDate |
2016-01-01 |
description |
We investigated the impact of chronic hypercorticosteronemia (due to neonatal monosodium L-glutamate, MSG, and treatment) on liver oxidative stress (OS), inflammation, and carbohydrate/lipid metabolism in adult male rats. We evaluated the peripheral concentrations of several metabolic and OS markers and insulin resistance indexes. In liver we assessed (a) OS (GSH and protein carbonyl groups) and inflammatory (IL-1b, TNFa, and PAI-1) biomarkers and (b) carbohydrate and lipid metabolisms. MSG rats displayed degenerated optic nerves, hypophagia, low body and liver weights, and enlarged adipose tissue mass; higher peripheral levels of glucose, triglycerides, insulin, uric acid, leptin, corticosterone, transaminases and TBARS, and peripheral and liver insulin resistance; elevated liver OS, inflammation markers, and glucokinase (mRNA/activity) and fructokinase (mRNA). Additionally, MSG liver phosphofructokinase-2, glucose-6-phosphatase (mRNA and activity) and glucose-6-phosphate dehydrogenase, Chrebp, Srebp1c, fatty acid synthase, and glycerol-3-phosphate (mRNAs) were increased. In conclusion adult MSG rats developed an insulin-resistant state and increased OS and serious hepatic dysfunction characterized by inflammation and metabolic signs suggesting increased lipogenesis. These features, shared by both metabolic and Cushing’s syndrome human phenotypes, support that a chronic glucocorticoid-rich endogenous environment mainly impacts on hepatic glucose cycle, displacing local metabolism to lipogenesis. Whether correcting the glucocorticoid-rich environment ameliorates such dysfunctions requires further investigation. |
url |
http://dx.doi.org/10.1155/2016/7838290 |
work_keys_str_mv |
AT hernangonzalovillagarcia chronicglucocorticoidrichmilieuandliverdysfunction AT vanesasabugo chronicglucocorticoidrichmilieuandliverdysfunction AT mariaceciliacastro chronicglucocorticoidrichmilieuandliverdysfunction AT guillermoschinella chronicglucocorticoidrichmilieuandliverdysfunction AT danielcastrogiovanni chronicglucocorticoidrichmilieuandliverdysfunction AT eduardospinedi chronicglucocorticoidrichmilieuandliverdysfunction AT marialauramassa chronicglucocorticoidrichmilieuandliverdysfunction AT flaviofrancini chronicglucocorticoidrichmilieuandliverdysfunction |
_version_ |
1725608228070359040 |